Bausch Health Companies (BHC) Set to Announce Quarterly Earnings on Thursday

Bausch Health Companies (TSE:BHC) is scheduled to be releasing its earnings data before the market opens on Thursday, May 2nd. Analysts expect Bausch Health Companies to post earnings of C$1.01 per share for the quarter.

Bausch Health Companies (TSE:BHC) last released its earnings results on Thursday, February 22nd. The company reported C$1.55 earnings per share for the quarter, beating the consensus estimate of C$1.36 by C$0.19. Bausch Health Companies had a negative net margin of 6.76% and a negative return on equity of 686.52%. The business had revenue of C$3.28 billion during the quarter, compared to analysts’ expectations of C$3.05 billion.

Bausch Health Companies Stock Up 0.6 %

BHC stock opened at C$11.73 on Thursday. Bausch Health Companies has a twelve month low of C$7.56 and a twelve month high of C$15.43. The company has a quick ratio of 0.58, a current ratio of 1.30 and a debt-to-equity ratio of 7,583.76. The company has a market cap of C$4.29 billion, a PE ratio of -5.33, a price-to-earnings-growth ratio of 0.21 and a beta of 0.83. The business’s 50-day simple moving average is C$12.62 and its 200 day simple moving average is C$11.07.

Analysts Set New Price Targets

Separately, Royal Bank of Canada boosted their price objective on Bausch Health Companies from C$8.00 to C$9.00 and gave the company a “sector perform” rating in a research report on Friday, February 23rd.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.